3rd Quarter - Amendment
THE MCMANUS GROUP for DENDREON PHARMACEUTICALS LLC
Firm
Client
Income
$10,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 21, 2019 | $10,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Aug 6, 2020 | $10,000 | Yes |
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part B payment reform. S. 2543, the Prescription Drug Pricing Reduction Act of 2019, and H.R. 3, the Lower Drug Costs Now Act of 2019.
Foreign entity interest: Dendreon is a subsidiary of Nanjing Xinjiekou Department Store, Co. Ltd. in China.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PAUL BRYAN CRONAN | — |
| CHRISTINA HOCHUL | — |
| JOHN MCMANUS | LA, Bill Thomas. Staff Director, W&M Health Subcommittee |
| BARRETT THORNHILL | LA, Sen. Crapo and Rep. Toomey. LA and Press Secretary, Rep. Norwood. |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.